This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Integrin 3D structures
From Proteopedia
(Difference between revisions)
| Line 73: | Line 73: | ||
**[[3vi4]] - hIG headpiece + antibody + peptide + Mg<br /> | **[[3vi4]] - hIG headpiece + antibody + peptide + Mg<br /> | ||
| - | *IG α-5 (CD49e) β-3 (CD61) ectodomain | + | *IG α-5 (CD49e) + IG β-3 (CD61) ectodomain |
**[[3ije]], [[1m1x]], [[4g1e]], [[4g1m]], [[1u8c]] – hIG + cation<br /> | **[[3ije]], [[1m1x]], [[4g1e]], [[4g1m]], [[1u8c]] – hIG + cation<br /> | ||
| Line 81: | Line 81: | ||
**[[1l5g]] - hIG + tripeptide + Mn<br /> | **[[1l5g]] - hIG + tripeptide + Mn<br /> | ||
| - | *IG α-5 β-6 | + | *IG α-5 + IG β-6 |
**[[4um8]] – hIG headpiece (mutant) + Ni<br /> | **[[4um8]] – hIG headpiece (mutant) + Ni<br /> | ||
| Line 88: | Line 88: | ||
**[[5neu]], [[5net]], [[5ner]], [[5nem]] – hIG headpiece + foot-and-mouth virus – Cryo EM<br /> | **[[5neu]], [[5net]], [[5ner]], [[5nem]] – hIG headpiece + foot-and-mouth virus – Cryo EM<br /> | ||
**[[5ffo]] – hIG headpiece + TGF-beta-1<br /> | **[[5ffo]] – hIG headpiece + TGF-beta-1<br /> | ||
| + | |||
| + | *IG α-6 + IG β-1 | ||
| + | **[[7ceb]], [[7cec]] – hIG headpiece + laminin + Mg<br /> | ||
| + | |||
| + | *IG α-L | ||
| + | |||
| + | **[[1lfa]] - hIG I domain + Mn <br /> | ||
| + | **[[1zon]], [[4ixd]] - hIG I domain <br /> | ||
| + | **[[1mqa]] - hIG I domain (mutant) <br /> | ||
| + | **[[1zoo]], [[1zop]], [[3f74]] - hIG I domain + Mg <br /> | ||
| + | **[[1mq9]] - hIG I domain (mutant) + Mn <br /> | ||
| + | **[[1mjn]] - hIG I domain (mutant) + Mg <br /> | ||
| + | **[[2k8o]] – hIG cytoplasmic domain (mutant) – NMR <br /> | ||
| + | **[[5e6s]], [[5e6r]] – hIG AI, headpiece,pocket domains + Mg<br /> | ||
| + | **[[2m3e]] – hIG transmembrane domain - NMR<br /> | ||
| + | |||
| + | *IG α-L complexes | ||
| + | |||
| + | **[[1cqp]] - hIG I domain + lovastatin + Mg <br /> | ||
| + | **[[1mq8]], [[3bn3]], [[3tcx]] - hIG I domain (mutant) + intracellular adhesion molecule + Mg <br /> | ||
| + | **[[1t0p]] - hIG I domain + intracellular adhesion molecule-3 + Mg<br /> | ||
| + | **[[1rd4]], [[2ica]], [[3bqm]], [[3bqn]], [[3e2m]] - hIG I domain + inhibitor<br /> | ||
| + | **[[2o7n]], [[3m6f]] - hIG I domain + antagonist<br /> | ||
| + | **[[1xdd]], [[1xdg]], [[1xuo]] - hIG I domain + inhibitor + Mg<br /> | ||
| + | **[[3f78]] - hIG I domain + anesthetic + Mg<br /> | ||
| + | **[[3eoa]], [[3eob]] - hIG I domain + antibody<br /> | ||
| + | **[[3hi6]] - hIG I domain (mutant) + antibody + Mn<br /> | ||
| + | |||
| + | *IG α-M | ||
| + | |||
| + | **[[1idn]], [[1na5]] - hIG<br /> | ||
| + | **[[1mf7]] - hIG (mutant) <br /> | ||
| + | **[[1bho]] - hIG + Mg<br /> | ||
| + | **[[1bhq]] - hIG + Cd<br /> | ||
| + | **[[1m1u]] - hIG (mutant) + Ca<br /> | ||
| + | **[[1n9z]] - hIG (mutant) + Mg<br /> | ||
| + | **[[3q3g]], [[3qa3]] – hIG + antibody<br /> | ||
| + | **[[4m76]] – hIG + complement C3<br /> | ||
| + | **[[2lke]], [[2lkj – hIG cytoplasmic domain – NMR<br /> | ||
| + | **[[4xw2]] – hIG + simvastatin<br /> | ||
| + | **[[6rhv]], [[6rhw]] – hIG + cytolysin<br /> | ||
| + | |||
*IG α-L | *IG α-L | ||
| Line 95: | Line 137: | ||
**[[2m3e]] – hIG transmembrane domain - NMR<br /> | **[[2m3e]] – hIG transmembrane domain - NMR<br /> | ||
| - | *IG α-L β-2 | + | *IG α-L + IG β-2 |
**[[5e6u]] – hIG headpiece (mutant) + Ni<br /> | **[[5e6u]] – hIG headpiece (mutant) + Ni<br /> | ||
| - | *IG α-V β-3 | + | *IG α-V + IG β-3 |
**[[6mk0]] – hIG + antagonist<br /> | **[[6mk0]] – hIG + antagonist<br /> | ||
| Line 106: | Line 148: | ||
**[[6naj]] – hIG + fibronectin<br /> | **[[6naj]] – hIG + fibronectin<br /> | ||
| - | *IG α-V β-8 | + | *IG α-V + IG β-8 |
**[[6djp]], [[6ujb]], [[6ujc]] – hIG + antibody – Cryo EM<br /> | **[[6djp]], [[6ujb]], [[6ujc]] – hIG + antibody – Cryo EM<br /> | ||
| Line 116: | Line 158: | ||
**[[2luv]] – hIG cytoplasmic domain – NMR<BR /> | **[[2luv]] – hIG cytoplasmic domain – NMR<BR /> | ||
| + | **[[1n3y]] – hIG domain I (mutant)<br /> | ||
| - | *IG α-X β-2 (CD18) | + | *IG α-X + IG β-2 (CD18) |
**[[3k6s]], [[3k71]], [[3k72]], [[5es4]] – hIG + Mg<br /> | **[[3k6s]], [[3k71]], [[3k72]], [[5es4]] – hIG + Mg<br /> | ||
| Line 139: | Line 182: | ||
**[[2l1c]] – hIG cytoplasmic tail + SHC<br /> | **[[2l1c]] – hIG cytoplasmic tail + SHC<br /> | ||
**[[2mtp]] – hIG cytoplasmic tail (mutant) + hIG α-2 β peptide+ filamin rod domain<br /> | **[[2mtp]] – hIG cytoplasmic tail (mutant) + hIG α-2 β peptide+ filamin rod domain<br /> | ||
| + | **[[6bxb]], [[6bxf]] – hIG/hIG α-L <br /> | ||
*IG β-4 (CD104; Gp150) | *IG β-4 (CD104; Gp150) | ||
Revision as of 08:59, 5 October 2021
3D structures of integrin
Updated on 05-October-2021 {{#tree:id=OrganizedByTopic|openlevels=0|
- IG CR3
- IG α-1 (CD49a)
- IG α-2 (CD49b)
- IG α-2b
- 2k1a - hIG transmembrane domain – NMR
- 2k1a - hIG transmembrane domain – NMR
- IG α-1 + IG β-1 (CD49a-CD49b)
- IG α-2 (CD49b) + IG β
- IG α-2b + IG β-3 (CD61)
- 1kup, 1kuz – hIG proximal domain – NMR
- 1m8o - hIG cytoplasmic domain – NMR
- 4cak – hIG – Cryo-EM
- 2k9j, 2knc, 7kn0 - hIG transmembrane domain – NMR
- 1tye, 3fcu, 3fcs – hIG + Mg
- 3fc3 – hIG (mutant) + Mg
- 2vc2, 2vdk, 2vdl, 3nid, 3nif, 3nig, 3zdx, 3zdy, 3zdz, 3ze0, 3ze1, 3ze2, 5hdb – hIG headpiece + antibody + Mg
- 4z7q, 4z7o, 4z7n – hIG headpiece + antibody + Mg + tetrapeptide
- 2vdm, 2vdn, 3t3m, 3t3p – hIG headpiece + antibody + antagonist + Mg
- 2vdo, 2vdp, 2vdq, 2vdr – hIG headpiece + antibody + fibrinogen peptide + Mg
- 6v4p – hIG + antibody – Cryo-EM
- 1kup, 1kuz – hIG proximal domain – NMR
- IG α-4
- 4irz - hIG + antibody
- 4irz - hIG + antibody
- IG α-4 (CD49d) + IG β-7
- IG α-5 (CD49e) + IG β-1 (CD29)
- IG α-5 (CD49e) + IG β-3 (CD61) ectodomain
- IG α-5 + IG β-6
- IG α-L
**2k8o – hIG cytoplasmic domain (mutant) – NMR
- IG α-L complexes
- 1cqp - hIG I domain + lovastatin + Mg
- 1mq8, 3bn3, 3tcx - hIG I domain (mutant) + intracellular adhesion molecule + Mg
- 1t0p - hIG I domain + intracellular adhesion molecule-3 + Mg
- 1rd4, 2ica, 3bqm, 3bqn, 3e2m - hIG I domain + inhibitor
- 2o7n, 3m6f - hIG I domain + antagonist
- 1xdd, 1xdg, 1xuo - hIG I domain + inhibitor + Mg
- 3f78 - hIG I domain + anesthetic + Mg
- 3eoa, 3eob - hIG I domain + antibody
- 3hi6 - hIG I domain (mutant) + antibody + Mn
- 1cqp - hIG I domain + lovastatin + Mg
- IG α-M
- IG α-L
- IG α-L + IG β-2
- 5e6u – hIG headpiece (mutant) + Ni
- 5e6u – hIG headpiece (mutant) + Ni
- IG α-V + IG β-3
- IG α-V + IG β-8
- IG α-X
- IG α-X + IG β-2 (CD18)
- IG β-1D
- 3g9w – hIG cytoplasmic tail + talin 2 F2-F3 domain
- 3g9w – hIG cytoplasmic tail + talin 2 F2-F3 domain
- IG β-2 (CD18)
- IG β-3 (CD61)
- IG β-4 (CD104; Gp150)
- 2f7q, 3f7r, 1qg3, 3f7q, 4wtw, 4wtx - hIG fibronectin type III domain
- 2yrz – hIG fibronectin type III domain – NMR
- 3f7p, 4q58 - hIG fibronectin type III domain + plectin-1
- 6gvl - hIG fibronectin type III domain + dystonin
- 6gvk - hIG fibronectin type III domain (mutant) + dystonin
- 3fq4, 3fso, 3h6a – hIG Calx-β domain
- 6hyf - rIG fibronectin type III domain
- 2f7q, 3f7r, 1qg3, 3f7q, 4wtw, 4wtx - hIG fibronectin type III domain
- IG β-7
}}
